Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Confirmatory study of TRK-820 Soft Capsules-Intractable Pruritus in Patients with Chronic Liver Disease-

Next Previous
Trial Profile

Confirmatory study of TRK-820 Soft Capsules-Intractable Pruritus in Patients with Chronic Liver Disease-

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 18 Sep 2017

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Nalfurafine (Primary)
  • Indications Pruritus
  • Focus Therapeutic Use
  • Sponsors Toray

Most Recent Events

  • 01 Sep 2017 Primary endpoint (STEP I, The difference in changes in VAS (week 4 [LOCF]) between the placebo and 5 microgram groups) has been met, according to result published in the Hepatology Research.
  • 01 Sep 2017 Primary endpoint (STEP II, The difference in changes in VAS (week 4 [LOCF]) between the placebo and 2.5 microgram groups) has been met, according to result published in the Hepatology Research.
  • 01 Sep 2017 Results assessing the efficacy and safety of the nalfurafine hydrochloride in the treatment of refractory pruritus in patients with chronic liver disease, were published in the Hepatology Research.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top